Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine vs Buprenorphine/Naloxone in Pregnant Women with Opioid Use Disorder
NCT03740243Phase 4Withdrawn
- Sponsor
- Stony Brook University
- Start
- Nov 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of buprenorphine + naloxone in opioid use disorder (OUD) (2 arms), sponsored by Stony Brook University. Primary endpoints: Compliance antepartum, Compliance postpartum and 2 more. Planned start Nov 2018; status: withdrawn.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03740243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740243.